Review



dnase i  (Zymo Research)


Bioz Verified Symbol Zymo Research is a verified supplier
Bioz Manufacturer Symbol Zymo Research manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Zymo Research dnase i
    Dnase I, supplied by Zymo Research, used in various techniques. Bioz Stars score: 95/100, based on 504 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dnase+i/DNase+I+Set+w%2F+DNA+Digestion+Buffer/pmc13759040-139-4-7
    Average 95 stars, based on 504 article reviews
    dnase i - by Bioz Stars, 2026-11
    95/100 stars

    Images

    Related Articles

    Lysis:

    Article Title: LMNA Haploinsufficiency in Human iPSC-Derived Cardiac Organoids Reveals Early Fibrotic Signaling as a Therapeutically Targetable Process
    Article Snippet: .. Protein lysates were prepared from cardiac organoid cell pellets using RIPA lysis buffer supplemented with protease inhibitor tablets (#05892970001, Roche) and 15U of DNAse I (#E1010, ZymoResearch). ..

    Protease Inhibitor:

    Article Title: LMNA Haploinsufficiency in Human iPSC-Derived Cardiac Organoids Reveals Early Fibrotic Signaling as a Therapeutically Targetable Process
    Article Snippet: .. Protein lysates were prepared from cardiac organoid cell pellets using RIPA lysis buffer supplemented with protease inhibitor tablets (#05892970001, Roche) and 15U of DNAse I (#E1010, ZymoResearch). ..

    Purification:

    Article Title: Rapid protamine evolution suppresses meiotic drive in Drosophila .
    Article Snippet: The mixture was incubated at 37°C for 30 min, followed by heat inactivation of proteinase K at 95°C for 3 min. For RNA extraction, we homogenized flies or specific tissues in TRIzol reagent (Invitrogen), added chloroform, and followed the manufacturer’s protocol for RNA extraction using the RNA Clean and Concentrator kit (Zymo Research) with deoxyribonuclease I (DNase I) to purify the RNA. .. Samples were treated with DNase I (Zymo Research) and further purified and concentrated using the same kit if there was still DNA contamination. .. The resulting RNA was reverse- transcribed into cDNA using SuperScript III FirstStrand Synthesis (Invitrogen Inc.).

    Article Title: Aminoacylated tRNA tails trigger auxiliary bacterial immunity
    Article Snippet: .. Residual genomic DNA was removed by treatment with DNase I (Zymo Research) for 15 min at room temperature, followed by purification using the RNA Clean & Concentrator-25 kit (Zymo Research). .. RNA concentration was initially measured using a NanoDrop spectrophotometer (Thermo Fisher Scientific).



    Similar Products

    99
    New England Biolabs dnase i
    Enhanced performance of Hypernova sensors. ( A ) RNase sensor. ( B ) Initial rates of light production of sensors that use either Hypernova (rHN) or Supernova (rSN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of RNase A. ( C ) DNase sensor. ( D ) Initial rates of light production of sensors that use either Hypernova (HN) or Supernova (SN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of DNase I. ( E ) APOBEC3A sensor. ( F ) Initial rates of light production of sensors that use either Hypernova (HN) or Supernova (aSN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of APOBEC3A. In all cases, N = 3, and error bars represent one standard deviation.
    Dnase I, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dnase+i/DNase+I/pmc13760218-107-14-16
    Average 99 stars, based on 1 article reviews
    dnase i - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    95
    Zymo Research dnase i
    Enhanced performance of Hypernova sensors. ( A ) RNase sensor. ( B ) Initial rates of light production of sensors that use either Hypernova (rHN) or Supernova (rSN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of RNase A. ( C ) DNase sensor. ( D ) Initial rates of light production of sensors that use either Hypernova (HN) or Supernova (SN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of DNase I. ( E ) APOBEC3A sensor. ( F ) Initial rates of light production of sensors that use either Hypernova (HN) or Supernova (aSN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of APOBEC3A. In all cases, N = 3, and error bars represent one standard deviation.
    Dnase I, supplied by Zymo Research, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dnase+i/DNase+I+Set+w%2F+DNA+Digestion+Buffer/pmc13759040-139-4-7
    Average 95 stars, based on 1 article reviews
    dnase i - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    96
    New England Biolabs dnase i reaction buffer
    Enhanced performance of Hypernova sensors. ( A ) RNase sensor. ( B ) Initial rates of light production of sensors that use either Hypernova (rHN) or Supernova (rSN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of RNase A. ( C ) DNase sensor. ( D ) Initial rates of light production of sensors that use either Hypernova (HN) or Supernova (SN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of DNase I. ( E ) APOBEC3A sensor. ( F ) Initial rates of light production of sensors that use either Hypernova (HN) or Supernova (aSN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of APOBEC3A. In all cases, N = 3, and error bars represent one standard deviation.
    Dnase I Reaction Buffer, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dnase+i/DNase+I+Reaction+Buffer/pmc13760218-107-6-16
    Average 96 stars, based on 1 article reviews
    dnase i reaction buffer - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    93
    MedChemExpress dnase i
    DNA-binding-dependent association between TCF3 and CXXC1 in promoting target gene transcription. ( A ) RNA-seq-derived expression changes in Pabpn1l in Tcf3 oo−/− and Cxxc1 oo−/− GV oocytes relative to their respective WT controls. Data are shown as log 2 fold changes. ( B ) Dual-luciferase reporter analysis of Pabpn1l promoter activity following expression of TCF3, CXXC1, or both proteins. The Btg4 promoter was used as a non-target control, and TCF12 was included as a paralog control. ( C ) Co-IP analysis of the association between ectopically expressed FLAG-TCF3 and HA-CXXC1 in HeLa cells with or without <t>DNase</t> <t>I</t> treatment. ( D ) Co-IP analysis of WT and DNA-binding-deficient TCF3 and CXXC1 proteins in GV oocytes following mRNA microinjection. The TCF3 E553A, R556A mutant is defective in sequence-specific DNA binding, whereas the CXXC1 C173A mutant is defective in CpG recognition. ( E ) Representative immunofluorescence images showing the localization of WT mCherry-TCF3 or the mCherry-TCF3 E553A, R556A mutant relative to H3K4me3 in GV oocytes following mRNA microinjection. Images showing the GV region only. Scale bar, 10 μm. Data in ( B ) are presented as mean ± SD. Adjusted P values in ( A ) were obtained from DESeq2 using the Wald test with Benjamini–Hochberg correction. Statistical significance in ( B ) was determined using one-way analysis of variance (ANOVA) followed by Tukey’s HSD post hoc test for multiple comparisons. n.s. not significant; * P < 0.05; ** P < 0.01; *** P < 0.001.
    Dnase I, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dnase+i/DNase+I%2C+Human/pmc13748978-116-5-10
    Average 93 stars, based on 1 article reviews
    dnase i - by Bioz Stars, 2026-11
    93/100 stars
      Buy from Supplier

    98
    New England Biolabs dnase i xt
    DNA-binding-dependent association between TCF3 and CXXC1 in promoting target gene transcription. ( A ) RNA-seq-derived expression changes in Pabpn1l in Tcf3 oo−/− and Cxxc1 oo−/− GV oocytes relative to their respective WT controls. Data are shown as log 2 fold changes. ( B ) Dual-luciferase reporter analysis of Pabpn1l promoter activity following expression of TCF3, CXXC1, or both proteins. The Btg4 promoter was used as a non-target control, and TCF12 was included as a paralog control. ( C ) Co-IP analysis of the association between ectopically expressed FLAG-TCF3 and HA-CXXC1 in HeLa cells with or without <t>DNase</t> <t>I</t> treatment. ( D ) Co-IP analysis of WT and DNA-binding-deficient TCF3 and CXXC1 proteins in GV oocytes following mRNA microinjection. The TCF3 E553A, R556A mutant is defective in sequence-specific DNA binding, whereas the CXXC1 C173A mutant is defective in CpG recognition. ( E ) Representative immunofluorescence images showing the localization of WT mCherry-TCF3 or the mCherry-TCF3 E553A, R556A mutant relative to H3K4me3 in GV oocytes following mRNA microinjection. Images showing the GV region only. Scale bar, 10 μm. Data in ( B ) are presented as mean ± SD. Adjusted P values in ( A ) were obtained from DESeq2 using the Wald test with Benjamini–Hochberg correction. Statistical significance in ( B ) was determined using one-way analysis of variance (ANOVA) followed by Tukey’s HSD post hoc test for multiple comparisons. n.s. not significant; * P < 0.05; ** P < 0.01; *** P < 0.001.
    Dnase I Xt, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dnase+i/DNase+I-XT/bio_rxiv__64898__2026__11__06__764861-328-4-7
    Average 98 stars, based on 1 article reviews
    dnase i xt - by Bioz Stars, 2026-11
    98/100 stars
      Buy from Supplier

    99
    Worthington Biochemical dnase i
    DNA-binding-dependent association between TCF3 and CXXC1 in promoting target gene transcription. ( A ) RNA-seq-derived expression changes in Pabpn1l in Tcf3 oo−/− and Cxxc1 oo−/− GV oocytes relative to their respective WT controls. Data are shown as log 2 fold changes. ( B ) Dual-luciferase reporter analysis of Pabpn1l promoter activity following expression of TCF3, CXXC1, or both proteins. The Btg4 promoter was used as a non-target control, and TCF12 was included as a paralog control. ( C ) Co-IP analysis of the association between ectopically expressed FLAG-TCF3 and HA-CXXC1 in HeLa cells with or without <t>DNase</t> <t>I</t> treatment. ( D ) Co-IP analysis of WT and DNA-binding-deficient TCF3 and CXXC1 proteins in GV oocytes following mRNA microinjection. The TCF3 E553A, R556A mutant is defective in sequence-specific DNA binding, whereas the CXXC1 C173A mutant is defective in CpG recognition. ( E ) Representative immunofluorescence images showing the localization of WT mCherry-TCF3 or the mCherry-TCF3 E553A, R556A mutant relative to H3K4me3 in GV oocytes following mRNA microinjection. Images showing the GV region only. Scale bar, 10 μm. Data in ( B ) are presented as mean ± SD. Adjusted P values in ( A ) were obtained from DESeq2 using the Wald test with Benjamini–Hochberg correction. Statistical significance in ( B ) was determined using one-way analysis of variance (ANOVA) followed by Tukey’s HSD post hoc test for multiple comparisons. n.s. not significant; * P < 0.05; ** P < 0.01; *** P < 0.001.
    Dnase I, supplied by Worthington Biochemical, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/dnase+i/Deoxyribonuclease+I/bio_rxiv__64898__2026__11__04__764362-103-37-40
    Average 99 stars, based on 1 article reviews
    dnase i - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    Image Search Results


    Enhanced performance of Hypernova sensors. ( A ) RNase sensor. ( B ) Initial rates of light production of sensors that use either Hypernova (rHN) or Supernova (rSN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of RNase A. ( C ) DNase sensor. ( D ) Initial rates of light production of sensors that use either Hypernova (HN) or Supernova (SN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of DNase I. ( E ) APOBEC3A sensor. ( F ) Initial rates of light production of sensors that use either Hypernova (HN) or Supernova (aSN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of APOBEC3A. In all cases, N = 3, and error bars represent one standard deviation.

    Journal: Nucleic Acids Research

    Article Title: Hypernova: a faster and brighter light-producing deoxyribozyme

    doi: 10.1093/nar/gkag1143

    Figure Lengend Snippet: Enhanced performance of Hypernova sensors. ( A ) RNase sensor. ( B ) Initial rates of light production of sensors that use either Hypernova (rHN) or Supernova (rSN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of RNase A. ( C ) DNase sensor. ( D ) Initial rates of light production of sensors that use either Hypernova (HN) or Supernova (SN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of DNase I. ( E ) APOBEC3A sensor. ( F ) Initial rates of light production of sensors that use either Hypernova (HN) or Supernova (aSN) as a signaling domain. Sensors were tested after preincubation in either the absence or presence of APOBEC3A. In all cases, N = 3, and error bars represent one standard deviation.

    Article Snippet: HPLC-purified oligonucleotides were incubated with 1× DNase I Reaction Buffer and 2 U of DNase I (NEB) in a total volume of 20 μl at 37°C for 30 min. Next, water and 5× selection buffer were added and samples were transferred to a white half-area 96-well plate (Corning).

    Techniques: Standard Deviation

    DNA-binding-dependent association between TCF3 and CXXC1 in promoting target gene transcription. ( A ) RNA-seq-derived expression changes in Pabpn1l in Tcf3 oo−/− and Cxxc1 oo−/− GV oocytes relative to their respective WT controls. Data are shown as log 2 fold changes. ( B ) Dual-luciferase reporter analysis of Pabpn1l promoter activity following expression of TCF3, CXXC1, or both proteins. The Btg4 promoter was used as a non-target control, and TCF12 was included as a paralog control. ( C ) Co-IP analysis of the association between ectopically expressed FLAG-TCF3 and HA-CXXC1 in HeLa cells with or without DNase I treatment. ( D ) Co-IP analysis of WT and DNA-binding-deficient TCF3 and CXXC1 proteins in GV oocytes following mRNA microinjection. The TCF3 E553A, R556A mutant is defective in sequence-specific DNA binding, whereas the CXXC1 C173A mutant is defective in CpG recognition. ( E ) Representative immunofluorescence images showing the localization of WT mCherry-TCF3 or the mCherry-TCF3 E553A, R556A mutant relative to H3K4me3 in GV oocytes following mRNA microinjection. Images showing the GV region only. Scale bar, 10 μm. Data in ( B ) are presented as mean ± SD. Adjusted P values in ( A ) were obtained from DESeq2 using the Wald test with Benjamini–Hochberg correction. Statistical significance in ( B ) was determined using one-way analysis of variance (ANOVA) followed by Tukey’s HSD post hoc test for multiple comparisons. n.s. not significant; * P < 0.05; ** P < 0.01; *** P < 0.001.

    Journal: Nucleic Acids Research

    Article Title: Transcription factor 3 cooperates with CXXC finger protein 1 to regulate histone H3K4 trimethylation and developmental competence in mouse oocytes

    doi: 10.1093/nar/gkag968

    Figure Lengend Snippet: DNA-binding-dependent association between TCF3 and CXXC1 in promoting target gene transcription. ( A ) RNA-seq-derived expression changes in Pabpn1l in Tcf3 oo−/− and Cxxc1 oo−/− GV oocytes relative to their respective WT controls. Data are shown as log 2 fold changes. ( B ) Dual-luciferase reporter analysis of Pabpn1l promoter activity following expression of TCF3, CXXC1, or both proteins. The Btg4 promoter was used as a non-target control, and TCF12 was included as a paralog control. ( C ) Co-IP analysis of the association between ectopically expressed FLAG-TCF3 and HA-CXXC1 in HeLa cells with or without DNase I treatment. ( D ) Co-IP analysis of WT and DNA-binding-deficient TCF3 and CXXC1 proteins in GV oocytes following mRNA microinjection. The TCF3 E553A, R556A mutant is defective in sequence-specific DNA binding, whereas the CXXC1 C173A mutant is defective in CpG recognition. ( E ) Representative immunofluorescence images showing the localization of WT mCherry-TCF3 or the mCherry-TCF3 E553A, R556A mutant relative to H3K4me3 in GV oocytes following mRNA microinjection. Images showing the GV region only. Scale bar, 10 μm. Data in ( B ) are presented as mean ± SD. Adjusted P values in ( A ) were obtained from DESeq2 using the Wald test with Benjamini–Hochberg correction. Statistical significance in ( B ) was determined using one-way analysis of variance (ANOVA) followed by Tukey’s HSD post hoc test for multiple comparisons. n.s. not significant; * P < 0.05; ** P < 0.01; *** P < 0.001.

    Article Snippet: To minimize DNA-mediated protein associations, DNase I (HY- P72974 , MCE) was added to the lysates at a final concentration of 0.1 mg/ml, followed by incubation on ice for 30 min. Lysates were clarified by centrifugation at 12 000× g for 15 min at 4°C, and an aliquot of each supernatant was retained as the input control.

    Techniques: Binding Assay, RNA Sequencing, Derivative Assay, Expressing, Luciferase, Analysis, Activity Assay, Control, Co-Immunoprecipitation Assay, Microinjection, Mutagenesis, Sequencing, Immunofluorescence, Reporter Assay